Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001900028 | SCV002123923 | uncertain significance | not provided | 2023-09-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 1362138). This variant has not been reported in the literature in individuals affected with CFH-related conditions. This variant is present in population databases (rs151068461, gnomAD 0.02%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 892 of the CFH protein (p.Ala892Val). |
Genome Diagnostics Laboratory, |
RCV002294489 | SCV002587665 | uncertain significance | Atypical hemolytic-uremic syndrome | 2020-05-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452008 | SCV004177344 | uncertain significance | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003456248 | SCV004177345 | uncertain significance | Age related macular degeneration 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452010 | SCV004177346 | uncertain significance | Basal laminar drusen | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452009 | SCV004177347 | uncertain significance | Factor H deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing |